ONO-5920/YM529 Confirmatory Study in Involutional Osteoporosis Patients

NCT00794443 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

692

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoporosis
Bone Loss, Age-Related

Interventions

DRUG: YM529 / ONO-5920

Sponsor

Astellas Pharma Inc

Collaborators

[object Object]